lilly tirzepatide vial Eli is considering offering more Zepbound doses in vials at lower cost Eli Lilly reduces price of

The decision of the courts could have a major impact on the outcome of Rybelsus lawsuits

High cardiovascular risk: Patients with multiple risk factors (diabetes, hypertension, high cholesterol, smoking history, family history) likely benefit, though direct trial evidence in lower-risk populations is less extensive

Therapeutic decision-making necessitates comprehensive consideration of individual patient characteristics, meticulous evaluation of the advantages and disadvantages of each modality, and transparent communication with patients and their families to collaboratively formulate the most appropriate treatment plan

Pituitary adenomas (Cushing's disease) are usually managed with trans-sphenoidal surgery as first-line treatment